Eidelman Virant Capital’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-3,357
| Closed | -$548K | – | 188 |
|
|
2021
Q1 | $548K | Sell |
3,357
-150
| -4% | -$24.3K | 0.22% | 92 |
|
|
2020
Q4 | $552K | Sell |
3,507
-1,010
| -22% | -$149K | 0.24% | 84 |
|
|
2020
Q3 | $671K | Buy |
4,517
+1,040
| +30% | +$154K | 0.37% | 60 |
|
|
2020
Q2 | $489K | Buy |
3,477
+100
| +3% | +$14.6K | 0.34% | 60 |
|
|
2020
Q1 | $443K | Sell |
3,377
-6
| -0.2% | -$851 | 0.46% | 57 |
|
|
2019
Q4 | $493K | Sell |
3,383
-150
| -4% | -$20.3K | 0.24% | 95 |
|
|
2019
Q3 | $457K | Sell |
3,533
-1,325
| -27% | -$175K | 0.26% | 85 |
|
|
2019
Q2 | $676K | Buy |
+4,858
| New | +$672K | 0.36% | 67 |
|
|
2018
Q4 | – | Sell |
-8,558
| Closed | -$1.18M | – | 115 |
|
|
2018
Q3 | $1.18M | Hold |
8,558
| – | – | 0.58% | 54 |
|
|
2018
Q2 | $1.04M | Hold |
8,558
| – | – | 0.64% | 46 |
|
|
2018
Q1 | $1.1M | Sell |
8,558
-654
| -7% | -$88.4K | 0.72% | 47 |
|
|
2017
Q4 | $1.29M | Sell |
9,212
-316
| -3% | -$44K | 0.75% | 47 |
|
|
2017
Q3 | $1.24M | Sell |
9,528
-200
| -2% | -$26.5K | 0.74% | 48 |
|
|
2017
Q2 | $1.29M | Sell |
9,728
-190
| -2% | -$24.2K | 0.74% | 50 |
|
|
2017
Q1 | $1.24M | Sell |
9,918
-1,650
| -14% | -$197K | 0.85% | 39 |
|
|
2016
Q4 | $1.33M | Buy |
11,568
+1,110
| +11% | +$128K | 0.76% | 42 |
|
|
2016
Q3 | $1.24M | Sell |
10,458
-57
| -0.5% | -$6.92K | 0.76% | 42 |
|
|
2016
Q2 | $1.27M | Sell |
10,515
-865
| -8% | -$98.3K | 0.78% | 40 |
|
|
2016
Q1 | $1.23M | Sell |
11,380
-243
| -2% | -$25.2K | 0.83% | 36 |
|
|
2015
Q4 | $1.19M | Buy |
11,623
+1,231
| +12% | +$124K | 0.72% | 45 |
|
|
2015
Q3 | $970K | Sell |
10,392
-25,066
| -71% | -$2.42M | 0.66% | 51 |
|
|
2015
Q2 | $3.46M | Sell |
35,458
-5,239
| -13% | -$525K | 1.55% | 21 |
|
|
2015
Q1 | $4.09M | Buy |
40,697
+750
| +2% | +$76.3K | 1.77% | 14 |
|
|
2014
Q4 | $4.18M | Buy |
39,947
+390
| +1% | +$41.1K | 1.85% | 11 |
|
|
2014
Q3 | $4.22M | Sell |
39,557
-500
| -1% | -$51.9K | 2.02% | 12 |
|
|
2014
Q2 | $4.19M | Sell |
40,057
-1,950
| -5% | -$197K | 1.73% | 14 |
|
|
2014
Q1 | $4.13M | Hold |
42,007
| – | – | 1.91% | 12 |
|
|
2013
Q4 | $3.85M | Sell |
42,007
-300
| -0.7% | -$27.6K | 1.63% | 18 |
|
|
2013
Q3 | $3.67M | Sell |
42,307
-1,149
| -3% | -$103K | 1.89% | 17 |
|
|
2013
Q2 | $3.73M | Buy |
+43,456
| New | +$3.69M | 2.19% | 12 |
|
Other funds holding JNJ
WA
Eidelman Virant Capital's JNJ Position: Q2 2021 in Review
Eidelman Virant Capital sold out of Johnson & Johnson (JNJ) in Q2 2021, closing a stake of 3,357 shares — an estimated $548K sold.
Eidelman Virant Capital first reported a position in JNJ in Q2 2013 and held it in 30 quarters. The position peaked at $4.22M in Q3 2014. 3,324 funds tracked by Wall St. Rank hold JNJ as of Q2 2021.
- Eidelman Virant Capital reported no remaining Johnson & Johnson position as of Q2 2021 after selling out during the quarter.
- Eidelman Virant Capital sold 3,357 Johnson & Johnson shares in Q2 2021, an estimated $548K.
- Eidelman Virant Capital first reported a position in Johnson & Johnson in Q2 2013 and held it in 30 quarters.
- Eidelman Virant Capital's Johnson & Johnson position peaked at $4.22M in Q3 2014.
- 3,324 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2021.
Based on Eidelman Virant Capital's 13F filing for Q2 2021, filed 19 Jul 2021.